BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 26035113)

  • 1. The diagnostic value of serum fucosylated fetuin A in hepatitis B virus-related liver diseases.
    Li L; Gu X; Fang M; Ji J; Yi C; Gao C
    Clin Chem Lab Med; 2016 Apr; 54(4):693-701. PubMed ID: 26035113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inter-alpha-trypsin inhibitor heavy chain H4 as a diagnostic and prognostic indicator in patients with hepatitis B virus-associated hepatocellular carcinoma.
    Noh CK; Kim SS; Kim DK; Lee HY; Cho HJ; Yoon SY; Lee GH; Hyun SA; Kim YJ; Kim HJ; Hwang JA; Ahn SJ; Shin SJ; Lee KM; Yoo BM; Cho SW; Cheong JY
    Clin Biochem; 2014 Sep; 47(13-14):1257-61. PubMed ID: 24836184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of serum clusterin as a surveillance tool for human hepatocellular carcinoma with hepatitis B virus related cirrhosis.
    Wang Y; Liu YH; Mai SJ; He LJ; Liao YJ; Deng HX; Guan XY; Zeng YX; Kung HF; Xie D
    J Gastroenterol Hepatol; 2010 Jun; 25(6):1123-8. PubMed ID: 20594228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum fucosylated paraoxonase 1 as a potential glycobiomarker for clinical diagnosis of early hepatocellular carcinoma using ELISA Index.
    Zhang S; Jiang K; Zhang Q; Guo K; Liu Y
    Glycoconj J; 2015 May; 32(3-4):119-25. PubMed ID: 25702281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APRI, the FIB-4 score, and Forn's index have noninvasive diagnostic value for liver fibrosis in patients with chronic hepatitis B.
    Ucar F; Sezer S; Ginis Z; Ozturk G; Albayrak A; Basar O; Ekiz F; Coban S; Yuksel O; Armutcu F; Akbal E
    Eur J Gastroenterol Hepatol; 2013 Sep; 25(9):1076-81. PubMed ID: 23510962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study.
    Shen Q; Fan J; Yang XR; Tan Y; Zhao W; Xu Y; Wang N; Niu Y; Wu Z; Zhou J; Qiu SJ; Shi YH; Yu B; Tang N; Chu W; Wang M; Wu J; Zhang Z; Yang S; Gu J; Wang H; Qin W
    Lancet Oncol; 2012 Aug; 13(8):817-26. PubMed ID: 22738799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble human leukocyte antigen-G expression in hepatitis B virus infection and hepatocellular carcinoma.
    Park Y; Park Y; Lim HS; Kim YS; Hong DJ; Kim HS
    Tissue Antigens; 2012 Feb; 79(2):97-103. PubMed ID: 22136460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in Red Blood Cell Distribution Width is Associated with Liver Function Parameters and Prognosis in Patients with Chronic HBV Liver Disease.
    Kai Y; Zishu G; Shihe G; Yufeng G; Qiang Z
    Clin Lab; 2016 Nov; 62(11):2197-2202. PubMed ID: 28164679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum paraoxonase 1 heteroplasmon, a fucosylated, and sialylated glycoprotein in distinguishing early hepatocellular carcinoma from liver cirrhosis patients.
    Sun C; Chen P; Chen Q; Sun L; Kang X; Qin X; Liu Y
    Acta Biochim Biophys Sin (Shanghai); 2012 Sep; 44(9):765-73. PubMed ID: 22751611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative evaluation of Golgi protein-73, fucosylated hemopexin, α-fetoprotein, and PIVKA-II in the serum of patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
    Morota K; Nakagawa M; Sekiya R; Hemken PM; Sokoll LJ; Elliott D; Chan DW; Dowell BL
    Clin Chem Lab Med; 2011 Apr; 49(4):711-8. PubMed ID: 21231906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum high-sensitivity C-reactive protein are associated with HBV replication, liver damage and fibrosis in patients with chronic hepatitis B.
    Ma LN; Liu XY; Luo X; Hu YC; Liu SW; Tang YY; Pan JL; Ding XC
    Hepatogastroenterology; 2015; 62(138):368-72. PubMed ID: 25916065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The discrepancy of HBsAg titre and HBV DNA in patients with chronic hepatitis B, HBV-related liver cirrhosis and hepatocellular carcinoma].
    Pei YZ; Han T; Ma XY; Li Y; Xing J; Song ZL
    Zhonghua Gan Zang Bing Za Zhi; 2011 Oct; 19(10):743-6. PubMed ID: 22409845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ELISA index of serum fucosylated haptoglobin for diagnosis of HCC using the normal and reverse AAL ELISA.
    Shang S; Qin X; Li W; Zhang S; Liu Y
    Discov Med; 2016 Jan; 21(113):15-23. PubMed ID: 26896598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Fucosylated Haptoglobin and Mac-2 Binding Protein as Serum Biomarkers to Estimate Liver Fibrosis in Patients with Chronic Hepatitis C.
    Tawara S; Tatsumi T; Iio S; Kobayashi I; Shigekawa M; Hikita H; Sakamori R; Hiramatsu N; Miyoshi E; Takehara T
    PLoS One; 2016; 11(3):e0151828. PubMed ID: 27002630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated plasma osteopontin level is predictive of cirrhosis in patients with hepatitis B infection.
    Zhao L; Li T; Wang Y; Pan Y; Ning H; Hui X; Xie H; Wang J; Han Y; Liu Z; Fan D
    Int J Clin Pract; 2008 Jul; 62(7):1056-62. PubMed ID: 17537188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of HBx-induced anti-URGs as early warning biomarker of cirrhosis and HCC.
    Wang W; Zhao LJ; Wang Y; Tao QY; Feitelson MA; Zhao P; Ren H; Qi ZT
    Cancer Biomark; 2011-2012; 11(1):29-39. PubMed ID: 22820138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential Serum Markers for Monitoring the Progression of Hepatitis B Virus-Associated Chronic Hepatic Lesions to Liver Cirrhosis.
    Wu C; Liu L; Zhao P; Tang D; Yao D; Zhu L; Wang Z
    Gut Liver; 2015 Sep; 9(5):665-71. PubMed ID: 25963079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum profiling based on fucosylated glycoproteins for differentiating between chronic hepatitis B and hepatocellular carcinoma.
    Liao J; Zhang R; Qian H; Cao L; Zhang Y; Xu W; Li J; Wu M; Yin Z
    Biochem Biophys Res Commun; 2012 Apr; 420(2):308-14. PubMed ID: 22425980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of B-cell activating factor in chronic hepatitis B virus infection: association with clinical diseases.
    Yang C; Li N; Wang Y; Zhang P; Zhu Q; Li F; Han Q; Lv Y; Yu L; Wei P; Liu Z
    J Interferon Cytokine Res; 2014 Oct; 34(10):787-94. PubMed ID: 24811691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.